Abdominal obesity, systolic blood pressure, and microalbuminuria in normotensive and euglycemic Korean men

International Journal of Obesity

Volumn 30, Issue 5, 2006, Pages 800-804

  Chang, Y ^a   Yoo, T ^a,b   Ryu, S ^a   Huh, B Y ^b   Cho, B L ^b   Sung, E ^a   Park, M ^b   Yoo, S H ^b  

^a Sungkyunkwan University   (South Korea)

^b Seoul National University Hospital   (South Korea)

Author keywords

Abdominal obesity; Blood pressure; Insulin resistance; Microalbuminuria; Multiple logistic regression analyses; Waist circumference

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CREATININE; GLUCOSE; INSULIN; LIPID;

ABDOMEN; ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CREATININE URINE LEVEL; DIASTOLIC BLOOD PRESSURE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; KOREA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTOLIC BLOOD PRESSURE; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ADULT; AGED; ALBUMINURIA; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CREATININE; CROSS-SECTIONAL STUDIES; HUMANS; INSULIN RESISTANCE; KOREA; LOGISTIC MODELS; MALE; MIDDLE AGED; OBESITY; SYSTOLE;

EID: 33646369173     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/sj.ijo.0803210     Document Type: Article

References (31)

1. Gerstein HC, Mann JF, Pogue J, Dinneen SF, Halle JP, Hoogwerf B et al. Prevalence and determinants of microalbuminuria in highrisk diabetic and nondiabetic patients in the Heart Outcomes Prevention Evaluation Study. The HOPE Study Investigators. Diabet Care 2000; 23 (Suppl. 2): B35-B39.
2. Deferrari G, Repetto M, Calvi C, Ciabattoni M, Rossi C, Robaudo C. Diabetic nephropathy: from micro- to macroalbuminuria. Nephrol Dial Transplant 1998; 13 (Suppl. 8): 11-15.
3. Rosa TT, Palatini P. Clinical value of microalbuminuria in hypertension. J Hypertens 2000; 18: 645-654.
4. Bigazzi R, Bianchi S, Campese VM, Baldari G. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension. Nephron 1992; 61: 94-97.
5. Jones CA, Francis ME, Eberhardt MS, Chavers B, Coresh J, Engelgau M et al. Microalbuminuria in the US population: third National Health and Nutrition Examination Survey. Am J Kidney Dis 2002; 39: 445-459.
6. Romundstad S, Holmen J, Hallan H, Kvenild K, Kruger O, Midthjell K. Microalbuminuria,cardiovascular disease and risk factors in a nondiabetic/nonhypertensive population. The Nord-Trøndelag Health Study (HUNT, 1995-97), Norway. J Intern Med 2002; 252: 164-172.
7. Hillege HL, Fidler V, Diercks GF, van Gilst WH, de Zeeuw D, van Veldhuisen DJ, et al., for the Prevention of Renal Vascular End Stage Disease (PREVEND) Study Group. Urinary albumin excretion predicts cardiovascular noncardiovascular mortality in general population. Circulation 2002; 106: 1777-1782.
8. Yuyun MF, Khaw KT, Luben R, Welch A, Bingham S, Day NE et al. Microalbuminuria, cardiovascular risk factors and cardiovascular morbidity in a British population: the EPIC-Norfolk population-based study. Eur J Cardiovasc Prev Rehabil 2004; 11: 207-213.
9. Forsblom CM, Forsblom CM, Eriksson JG, Ekstrand AV, Teppo AM, Taskinen MR et al. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 1995; 38: 363-369.
10. Kim YI, Kim CH, Choi CS, Chung YE, Lee MS, Lee SI et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabet Res Clin Pract 2001; 52: 145-152.
11. Mykkanen L, Zaccaro DJ, Wagenknecht LE, Robbins DC, Gabriel M, Haffner SM. Microalbuminuria is associated with insulin resistance in nondiabetic subjects: the insulin resistance atherosclerosis study. Diabetes 1998; 47: 793-800.
12. Hoffmann IS, Jimenez E, Cubeddu LX. Urinary albumin excretion in lean, overweight and obese glucose tolerant individuals: its relationship with dyslipidaemia, hyperinsulinaemia and blood pressure. J Hum Hypertens 2001; 15: 407-412.
13. Nielsen S, Jensen MD. Relationship between urinary albumin excretion, body composition, and hyperinsulinemia in normotensive glucose-tolerant adults. Diabet Care 1999; 22: 1728-1733.
14. Srinivasan SR, Myers L, Berenson GS. Risk variables of insulin resistance syndrome in African-American and Caucasian young adults with microalbuminuria: the Bogalusa Heart Study. Am J Hypertens 2000; 13: 1274-1279.
15. Pedrinelli R, Dell'Omo G, Giampietro O, Giorgi D, Di Bello V, Bandinelli S et al. Dissociation between albuminuria and insulinaemia in hypertensive and atherosclerotic men. J Hum Hypertens 1999; 13: 129-134.
16. Cirillo M, Senigalliesi L, Laurenzi M, Alfieri R, Stamler J, Stamler R et al. Microalbuminuria in nondiabetic adults: relation of blood pressure, body mass index, plasma cholesterol levels, and smoking: The Gubbio Population Study. Arch Intern Med 1998; 158: 1933-1939.
17. Knight EL, Kramer HM, Curhan GC. High-normal blood pressure and microalbuminuria. Am J Kidney Dis 2003; 41: 588-595.
18. Pinto-Sietsma SJ, Navis G, Janssen WM, de Zeeuw D, Gans RO, de Jong PE. A central body fat distribution is related to renal function impairment, even in lean subjects. Am J Kidney Dis 2003; 41: 733-741.
19. Basdevant A, Cassuto D, Gibault T, Raison J, Guy-Grand B. Microalbuminuria and body fat distribution in obese subjects. Int J Obes Relat Metab Disord 1994; 18: 806-811.
20. Metcalf PA, Scragg RK, Dryson E. Associations between body morphology and microalbuminuria in healthy middle-aged European, Maori and Pacific Island New Zealanders. Int J Obes Relat Metab Disord 1997; 21: 203-210.
21. Mulyadi L, Stevens C, Munro S, Lingard J, Bermingham M. Body fat distribution and total body fat as risk factors for microalbuminuria in the obese. Ann Nutr Metab 2001; 45: 67-71.
22. Rosenbaum P, Gimeno SG, Sanudo A, Franco LJ, Ferreira SR, Japanese-Brazilian Diabetes Study Group. Independent impact of glycemia and blood pressure in albuminuria on high-risk subjects for metabolic syndrome. Clin Nephrol 2004; 61: 369-376.
23. Palaniappan L, Carnethon M, Fortmann SP. Association between microalbuminuria and the metabolic syndrome: NHANES III. Am J Hypertens 2003; 16: 952-958.
24. Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, et al., Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabet Care 2003; 26: 3160-3167.
25. WHO Western Pacific Region, IASO and IOTF. The Asia-Pacific Perspective: Redefining Obesity and Its Treatment. Health Communications Australia Pty Limit: Sydney, Australia, 2000.
26. Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497.
27. Bosma RJ, van der Heide JJ, Oosterop EJ, de Jong PE, Navis G. Body mass index is associated with altered renal hemodynamics in non-obese healthy subjects. Kidney Int 2004; 65: 259-265.
28. de Jong PE, Verhave JC, Pinto-Sietsma SJ, Hillege HL, PREVEND study group. Obesity and target organ damage: the kidney. Int J Obes Relat Metab Disord 2002; 26: S21-S24.
29. Martinez MA, Moreno A, Aguirre de Carcer A, Cabrera R, Rocha R, Torre A, et al., MAPA - Madrid Working Group. Frequency and determinants of microalbuminuria in mild hypertension: a primary-care-based study. J Hypertens 2001; 19: 319-326.
30. Wang W, Zhao D, Liu J, Sun JY, Wu GX, Zeng ZC et al. A prospective study of relationship between blood pressure and 10-year cardiovascular risk in a Chinese cohort aged 35-64 years. Zhonghua Nei Ke Za Zhi 2004; 43: 730-734.
31. American Diabetes Association. Diabetic nephropathy. Diabet Care 2003; 23: S421-S426.